Simrat Randhawa
Evp, Head Of R&D at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,60024,524 held (−10%) | $105.19 | $273K | -21.7% |
| Sep 3SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 7,21517,309 held (−29%) | $106.25 | $767K | -22.5% |
| Sep 3SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 13,3094,000 held (−77%) | $106.74 | $1.4M | -22.8% |
| Jun 2SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 5,42825,102 held (−18%) | $89.72 | $487K | -8.2% |
| Jun 2SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 16,9438,159 held (−67%) | $90.72 | $1.5M | -9.2% |
| Jun 2SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 4,1594,000 held (−51%) | $91.37 | $380K | -9.9% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 33,830 | $81.48 | $2.8M | +1.1% |
| Nov 14SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 26,16665,341 held (−29%) | $35.80 | $937K | +130.1% |
| Nov 14SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 42,76522,576 held (−65%) | $37.04 | $1.6M | +122.4% |
| Nov 14SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 18,5764,000 held (−82%) | $37.72 | $701K | +118.4% |
| Nov 14SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 109,0314,000 held (−96%) | $38.14 | $4.2M | +116.0% |
- Sell
Evp, Head Of R&D Simrat Randhawa sold $273K of DNTH at $105.19 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D Simrat Randhawa sold $767K of DNTH at $106.25 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D Simrat Randhawa sold $1.4M of DNTH at $106.74 — cuts the stake by 77%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D Simrat Randhawa sold $487K of DNTH at $89.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D Simrat Randhawa sold $1.5M of DNTH at $90.72 — cuts the stake by 67%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D Simrat Randhawa sold $380K of DNTH at $91.37 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.